These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 386212)

  • 1. Treatment of advanced prostatic cancer with flutamide.
    Sanford EJ; Bowditch RR; Rohner TJ; Bardin CW
    Pa Med; 1979 Sep; 82(9):29-31. PubMed ID: 386212
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of flutamide (SCH-13521) and diethylstilbestrol in untreated advanced prostatic cancer.
    Jacobo E; Schmidt JD; Weinstein SH; Flocks RH
    Urology; 1976 Sep; 8(3):231-3. PubMed ID: 788293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of flutamide as monotherapy in the treatment of advanced prostate cancer.
    Newling DW
    Prog Clin Biol Res; 1989; 303():117-21. PubMed ID: 2674980
    [No Abstract]   [Full Text] [Related]  

  • 4. Flutamide therapy for carcinoma of the prostate.
    Airhart RA; Barnett TF; Sullivan JW; Levine RL; Schlegel JU
    South Med J; 1978 Jul; 71(7):798-801. PubMed ID: 78529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of flutamide. A new agent in the treatment of advanced prostatic cancer.
    Sarfaty GA; Alder SJ; McLean RG
    Med J Aust; 1984 Feb; 140(4):219-21. PubMed ID: 6694625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined androgen blockade: leuprolide and flutamide versus leuprolide and placebo.
    Crawford ED; Goodman P; Blumenstein B
    Semin Urol; 1990 Aug; 8(3):154-8. PubMed ID: 2119048
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Zoladex' versus 'Zoladex' plus flutamide in the treatment of advanced prostate cancer. First interim analysis of an international trial. International Prostate Cancer Study Group.
    Lunglmayr G
    Prog Clin Biol Res; 1989; 303():145-51. PubMed ID: 2528737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flutamide versus stilboestrol in the management of advanced prostatic cancer. A controlled prospective study.
    Lund F; Rasmussen F
    Br J Urol; 1988 Feb; 61(2):140-2. PubMed ID: 3280080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flutamide approved for prostate cancer.
    Oncology (Williston Park); 1989 Mar; 3(3):135. PubMed ID: 2518157
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination therapy with flutamide and castration: its benefits at various stages of prostate cancer.
    Labrie F; Dupont A; Cusan L; Manhès G; Bergeron N; Lacourcière Y; Pineault S; Bélanger A; Monfette G; Emond J
    Prog Clin Biol Res; 1989; 303():161-7. PubMed ID: 2674982
    [No Abstract]   [Full Text] [Related]  

  • 11. Flutamide therapy for advanced prostatic cancer: a phase II study.
    MacFarlane JR; Tolley DA
    Br J Urol; 1985 Apr; 57(2):172-4. PubMed ID: 3986452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flutamide for prostate cancer.
    Med Lett Drugs Ther; 1989 Jul; 31(797):72. PubMed ID: 2501635
    [No Abstract]   [Full Text] [Related]  

  • 13. A new antiprostatic agent for treatment of prostatic carcinoma.
    Irwin RJ; Prout GR
    Surg Forum; 1973; 24():536-7. PubMed ID: 4806089
    [No Abstract]   [Full Text] [Related]  

  • 14. Is there a role for pure antiandrogens in the treatment of advanced prostatic cancer?
    Pavone-Macaluso M; Serretta V; Daricello G; Pavone C; Cacciatore M; Romano C; Cavallo N
    Prog Clin Biol Res; 1990; 350():149-57. PubMed ID: 2201041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
    Labrie F; Dupont A; Giguère M; Borsanyi JP; Lacourciere Y; Bélanger A; Lachance R; Emond J; Monfette G
    Prog Clin Biol Res; 1988; 260():41-62. PubMed ID: 3283766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy.
    Sogani PC; Vagaiwala MR; Whitmore WF
    Cancer; 1984 Aug; 54(4):744-50. PubMed ID: 6378356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoladex and flutamide vs orchidectomy: a phase III EORTC 30853 trial. EORTC Urological Group.
    Carvalho AP; de Moura JL; Denis L; Newling D; Smith P; Bono A; Sylvester R; De Pauw M; Ongena P
    Prog Clin Biol Res; 1989; 303():129-43. PubMed ID: 2528736
    [No Abstract]   [Full Text] [Related]  

  • 18. Leuprolide with flutamide for complete androgen ablation: therapeutic alternative for advanced prostatic cancer (stage D2).
    Chime-Udeh E
    Conn Med; 1991 Sep; 55(9):526-8. PubMed ID: 1748007
    [No Abstract]   [Full Text] [Related]  

  • 19. Experience with flutamide in previously untreated patients with advanced prostatic cancer.
    Sogani PC; Whitmore WF
    J Urol; 1979 Nov; 122(5):640-3. PubMed ID: 501817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complete androgen blockade (orchiectomy + flutamide) versus androgen blockade with cytostasis (orchiectomy + estramustine) in the treatment of virginal advanced prostate cancer].
    Flamm J; Fischer M
    Wien Klin Wochenschr; 1988 Sep; 100(17):589-92. PubMed ID: 3055689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.